Sometimes, cancer cells that have spread become ‘dormant’ but can start proliferating again later. A cue that can reactivate ...

Hidden in the lungs of some breast cancer survivors are tumour cells that can remain dormant for decades — until they one day ...

Weill Cornell Medicine researchers have discovered that PD-1—a molecule best known for putting the brakes on immune ...

Researchers have discovered a way to make the immune system's T cells significantly more effective at fighting cancer. By ...

New designer proteins created using an AI tool can selectively target peptide segments that bind to markers on diseased ...

Investigators led by Navdeep Chandel, Ph.D., the David W. Cugell, MD, Professor of Medicine in the Division of Pulmonary and ...

Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to ...

He made a conceptual leap in immunotherapy by creating a hybrid T-cell, known as CAR-T, that was genetically modified to ...

CAR T-cell therapy is a one-time treatment, but it costs hundreds of thousands of dollars. And when you add in related costs, like hospital stays and home health care, the total may be closer to ...

In fighting chronic infections or certain cancers, CD8+ T cells—the immune system's frontline soldiers—eventually become ...

A new AI tool that models how variations in peptides change T cell receptor binding could help design immunotherapies with ...